Data / Form D filings / Enumeral Biomedical Corp.
Enumeral Biomedical Corp.: Form D filings
Enumeral Biomedical Corp., a biotechnology company in New York, NY, filed 5 Form D notices with the SEC between 2011 and 2014. The latest, on May 7, 2014, reports $2 million sold of an offering with no set size to 5 investors.
Find out what Enumeral Biomedical Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1450 BROADWAY, 24TH FLOOR, New York, NY, 10018
- Phone
- (347) 277-4787
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1518957
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2014 | New notice | Indefinite | $2,016,250 | Indefinite | 5 | Apr 25, 2014 | sec.gov |
| Feb 10, 2014 | New notice | $750,000 | $635,000 | $115,000 | 6 | Feb 3, 2014 | sec.gov |
| May 14, 2013 | New notice | Indefinite | $1,520,004 | Indefinite | 10 | Apr 30, 2013 | sec.gov |
| Jul 9, 2012 | New notice | $3,000,000 | $2,272,973 | $727,027 | 17 | Jun 27, 2012 | sec.gov |
| Apr 29, 2011 | New notice | $3,339,640 | $1,997,477 | $1,342,163 | 10 | Apr 19, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Emanuele H. Ostuni | Director | |
| Michael H. Weiss | Director | |
| Arthur H. Tinkelenberg | Executive Officer, Director | |
| Allan H. Rothstein | Director | |
| Barry H. Buckland | Director | |
| Derek H. Brand | Executive Officer | |
| John H. Rydzewski | Executive Officer, Director | |
| Daniel H. Wolfe | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of May 5, 2014 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Enumeral Biomedical Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.